Cargando…
Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma
It is common knowledge that cancer patients are more prone to develop venous thromboembolic complications (VTE). It is therefore not surprising that patients with hepatocellular carcinoma (HCC) present with a significant risk of VTE, with the portal vein being the most frequent site (PVT). However,...
Autores principales: | Zanetto, Alberto, Campello, Elena, Spiezia, Luca, Burra, Patrizia, Simioni, Paolo, Russo, Francesco Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266984/ https://www.ncbi.nlm.nih.gov/pubmed/30453547 http://dx.doi.org/10.3390/cancers10110450 |
Ejemplares similares
-
Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis
por: Zanetto, Alberto, et al.
Publicado: (2021) -
Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute‐on‐chronic liver failure
por: Campello, Elena, et al.
Publicado: (2021) -
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC
por: Zanetto, Alberto, et al.
Publicado: (2021) -
Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
por: Russo, Francesco Paolo, et al.
Publicado: (2022) -
COVID-19 and liver disease: where are we now?
por: Russo, Francesco Paolo, et al.
Publicado: (2022)